• Image of Restoril medication Image of Restoril medication
    • TEMAZEPAM (Generic for RESTORIL)

    • QTY 30
    • 7.5 MG
    • Capsule
    • Near  77381

TEMAZEPAM (te MAZ e pam) treats insomnia. It helps you go to sleep faster and stay asleep through the night. It is often used for a short period of time. It belongs to a group of medications called benzodiazepines.


What does TEMAZEPAM (Generic for RESTORIL) look like?

View images of TEMAZEPAM (Generic for RESTORIL) and identify pills by imprint, color or shape. If you need to save money on your TEMAZEPAM (Generic for RESTORIL), compare our prices. Our prescription savings may even be lower than your insurance copay!

Note: Multiple images may be displayed for medicines available in different strengths, sold under different brand names, or manufactured by different pharmaceutical companies.

Temazepam 7.5mg Capsule
Temazepam 7.5mg Capsule

Strength: 7.5 MG

Pill Imprint: 7.5 mg 7.5 mg FOR SLEEP M

Color: blue

Shape: capsule

Temazepam 7.5mg Capsule
Temazepam 7.5mg Capsule

Strength: 7.5 MG

Pill Imprint: 7.5 mg Novel 120

Color: pink

Shape: capsule

Temazepam 7.5mg Capsule
Temazepam 7.5mg Capsule

Strength: 7.5 MG

Pill Imprint: A222

Color: blue

Shape: capsule

Temazepam 7.5mg Capsule
Temazepam 7.5mg Capsule

Strength: 7.5 MG

Pill Imprint: FOR SLEEP M 7.5 mg 7.5mg

Color: blue

Shape: capsule

Temazepam 7.5mg Capsule
Temazepam 7.5mg Capsule

Strength: 7.5 MG

Pill Imprint: MUTUAL 866 MUTUAL 866

Color: blue-green

Shape: capsule

Temazepam 7.5mg Capsule
Temazepam 7.5mg Capsule

Strength: 7.5 MG

Pill Imprint: MYLAN 3110 MYLAN 3110

Color: beige

Shape: capsule

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.